Sawai Receives Approval for Vardenafil Tablets
2020-06-05 · Upsher-Smith Laboratories · original upsher-smith.com ↗
Osaka, Japan – June 3, 2020 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approval by the Ministry of Health, Labour and Welfare (MHLW) for Vardenafil tablets (the branded product: LEVITRA®). Vardenafil tablets are prescribed for the treatment of erectile dysfunction. The products approved by MHLW on June 3. Product Name: VARDENAFIL Tablets 10 mg [SAWAI], 20 mg [SAWAI] Generic name: Vardenafil Brand products: LEVITRA® 10 mg, 20 mg The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.
The release as fetched from its publisher. upsher-smith.com ↗